Erythropoietin inhibits γ-irradiation-induced apoptosis by upregulation of Bcl-2 and decreasing the activation of caspase 3 in human UT-7/erythropoietin cell line

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 5-6, 2010, Pages 624-629

  Liu, Yuan Yuan ^a   She, Zhen Jue ^a   Yao, Ming Hui ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

irradiation; Apoptosis; Bcl 2; Bcl 2 Bax ratio; Caspase 3; Erythropoietin; UT 7 EPO cell line

Indexed keywords

CASPASE 3; CELL PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P12; PROTEIN P17; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG; ERYTHROPOIETIN; RECOMBINANT PROTEIN;

APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL MATURATION; CELL PROLIFERATION; CELL PROTECTION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; ERYTHROID PRECURSOR CELL; ERYTHROLEUKEMIA CELL; GAMMA IRRADIATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RADIATION EXPOSURE; UPREGULATION; BIOSYNTHESIS; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; GAMMA RADIATION; METABOLISM; RADIATION RESPONSE; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ERYTHROPOIETIN, RECOMBINANT; GAMMA RAYS; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; UP-REGULATION; ERYTHROPOIETIN; RECOMBINANT PROTEINS;

EID: 77951107360     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2010.05370.x     Document Type: Article

References (30)

1. Nunia V, Goyal PK. Prevention of gamma radiation induced anaemia in mice by diltiazem. J. Radiat. Res. (Tokyo) 2004 45 : 11 17.
2. Henke M, Laszig R, Rube C et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: Randomised, double-blind, placebo-controlled trial. Lancet 2003 362 : 1255 1260.
3. Rades D, Schild SE, Yekebas EF, Job H, Schwarz R, Rudat V. Epoetin-alpha during radiotherapy for stage III esophageal carcinoma. Cancer 2005 103 : 2274 2279.
4. Scagliotti GV, Novello S. Role of erythropoietin in the treatment of lung cancer associated anaemia. Lung Cancer 2001 34 (Suppl 4 S91 4.
5. Constantinescu SN, Ghaffari S, Lodish HF. The Erythropoietin Receptor: Structure, activation and intracellular signal transduction. Trends Endocrinol. Metab. 1999 10 : 18 23.
6. Socolovsky M, Fallon AE, Wang S, Brugnara C, Lodish HF. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: A direct role for Stat5 in Bcl-X(L) induction. Cell 1999 98 : 181 191.
7. Wagner KU, Claudio E, Rucker EB et al. Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. Development 2000 127 : 4949 4958.
8. Silva M, Grillot D, Benito A, Richard C, Nunez G, Fernandez-Luna JL. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 1996 88 : 1576 1582.
9. Silva M, Benito A, Sanz C et al. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines. J. Biol. Chem. 1999 274 : 22165 22169.
10. Quelle FW, Wang J, Feng J et al. Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways. Genes Dev. 1998 12 : 1099 1107.
11. Henry MK, Lynch JT, Eapen AK, Quelle FW. DNA damage-induced cell-cycle arrest of hematopoietic cells is overridden by activation of the PI-3 kinase/Akt signaling pathway. Blood 2001 98 : 834 841.
12. Mori M, Uchida M, Watanabe T et al. Activation of extracellular signal-regulated kinases ERK1 and ERK2 induces Bcl-xL up-regulation via inhibition of caspase activities in erythropoietin signaling. J. Cell. Physiol. 2003 195 : 290 297.
13. Sae-Ung N, Matsushima T, Choi I et al. Role of NF-kappa B in regulation of apoptosis of erythroid progenitor cells. Eur. J. Haematol. 2005 74 : 315 323.
14. Choi I, Muta K, Wickrema A, Krantz SB, Nishimura J, Nawata H. Interferon gamma delays apoptosis of mature erythroid progenitor cells in the absence of erythropoietin. Blood 2000 95 : 3742 3749.
15. Lee JH, Lee YM, Park JW. Regulation of ionizing radiation-induced apoptosis by a manganese porphyrin complex. Biochem. Biophys. Res. Commun. 2005 334 : 298 305.
16. BenJilani KE, Gaillard JP, Petit F et al. A suppressive effect of the adenovirus 5 protein E1B 55K on apoptosis induced by IL-3 deprivation and gamma-irradiation. Biol. Cell 2002 94 : 77 89.
17. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 1999 13 : 1899 1911.
18. Yu Y, Little JB. p53 is involved in but not required for ionizing radiation-induced caspase-3 activation and apoptosis in human lymphoblast cell lines. Cancer Res. 1998 58 : 4277 4281.
19. Kumar P, Coltas IK, Kumar B, Chepeha DB, Bradford CR, Polverini PJ. Bcl-2 protects endothelial cells against gamma-radiation via a Raf-MEK-ERK-survivin signaling pathway that is independent of cytochrome c release. Cancer Res. 2007 67 : 1193 1202.
20. Morita Y, Naka T, Kawazoe Y et al. Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alpha-induced cell death in fibroblasts. Proc. Natl. Acad. Sci. U S A 2000 97 : 5405 5410.
21. Beneduci A, Chidichimo G, Tripepi S, Perrotta E, Cufone F. Antiproliferative effect of millimeter radiation on human erythromyeloid leukemia cell line K562 in culture: Ultrastructural- and metabolic-induced changes. Bioelectrochemistry 2007 70 : 214 220.
22. Komatsu N, Yamamoto M, Fujita H et al. Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7. Blood 1993 82 : 456 464.
23. Kadri Z, Petitfrere E, Boudot C et al. Erythropoietin induction of tissue inhibitors of metalloproteinase-1 expression and secretion is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways. Cell Growth Differ. 2000 11 : 573 580.
24. Corapcioglu F, Aksu G, Basar EZ, Demirel A, Oncel S, Mutlu A. Recombinant human erythropoietin beta therapy: An effective strategy to reduce transfusion requirement in children receiving anticancer treatment. Pediatr. Hematol. Oncol. 2008 25 : 509 521.
25. Varlotto J, Stevenson MA. Anemia, tumor hypoxemia, and the cancer patient. Int. J. Radiat. Oncol. Biol. Phys. 2005 63 : 25 36.
26. Ots PM, Perez AR, Carrizosa CL et al. Once-weekly dose of epoetinum alfa in cancer patients with anemia receiving radiotherapy. Clin. Transl. Oncol. 2005 7 : 486 492.
27. Ogilvy S, Metcalf D, Print CG, Bath ML, Harris AW, Adams JM. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc. Natl. Acad. Sci. U S A 1999 96 : 14943 14948.
28. Dainiak N. Hematologic consequences of exposure to ionizing radiation. Exp. Hematol. 2002 30 : 513 528.
29. Dunst J. Management of anemia in patients undergoing curative radiotherapy. Erythropoietin, transfusions, or better nothing? Strahlenther. Onkol. 2004 180 : 671 681.
30. Blackwell K, Gascon P, Sigounas G, Jolliffe L. rHuEPO and improved treatment outcomes: Potential modes of action. Oncologist 2004 9 (Suppl 5 41 7.